메뉴 건너뛰기




Volumn 389, Issue 10088, 2017, Pages 2469-2470

WHO R&D Blueprint: a global coordination mechanism for R&D preparedness

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE;

EID: 85033221795     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31635-5     Document Type: Letter
Times cited : (27)

References (6)
  • 1
  • 2
    • 85032507806 scopus 로고    scopus 로고
    • Clinical trials during epidemics
    • Keusch, GT, McAdam, KPJW, Clinical trials during epidemics. Lancet 389 (2017), 2455–2457.
    • (2017) Lancet , vol.389 , pp. 2455-2457
    • Keusch, G.T.1    McAdam, K.P.J.W.2
  • 3
    • 84953249210 scopus 로고    scopus 로고
    • Emergencies preparedness, response
    • (accessed June 3, 2017).
    • WHO. Emergencies preparedness, response. http://www.who.int/blueprint/en/ (accessed June 3, 2017).
  • 4
    • 85010755634 scopus 로고    scopus 로고
    • Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
    • Henao-Restrepo, AM, Camacho, A, Longini, IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 389 (2017), 505–518.
    • (2017) Lancet , vol.389 , pp. 505-518
    • Henao-Restrepo, A.M.1    Camacho, A.2    Longini, I.M.3
  • 5
    • 85033242771 scopus 로고    scopus 로고
    • Emergencies preparedness, response: Priority diseases needing R&D actions
    • (accessed June 3, 2017).
    • WHO. Emergencies preparedness, response: Priority diseases needing R&D actions. http://www.who.int/blueprint/priority-diseases/en/ (accessed June 3, 2017).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.